Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
Holding SLNO?
Track your performance easily

Soleno Therapeutics (SLNO) Financial Statements

707 Followers

Soleno Therapeutics Financial Overview

Soleno Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.434; its P/E ratio is -22.56; Soleno Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -21.85M$ -21.00M$ -8.82M$ -7.85M$ -8.36M
EBITDA$ -20.89M$ -20.98M$ -8.33M-$ -7.87M
Net Income Common Stockholders$ -21.85M$ -21.40M$ -10.86M$ -8.47M$ -8.36M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 266.12M$ 149.63M$ 52.44M$ 19.37M$ 7.87M
Total Assets$ 304.13M$ 168.84M$ 63.55M$ 30.94M$ 19.51M
Total Debt$ 296.00K$ 347.00K$ 470.00K$ 485.00K$ 39.00K
Net Debt$ -265.83M$ -149.28M$ -51.97M$ -18.88M$ -7.83M
Total Liabilities$ 22.74M$ 25.45M$ 40.33M$ 18.52M$ 16.89M
Stockholders Equity$ 281.39M$ 143.39M$ 23.22M$ 12.43M$ 2.64M
Cash Flow-
Free Cash Flow$ -17.71M$ -12.51M$ -6.30M-$ -6.73M
Operating Cash Flow$ -17.70M$ -12.50M$ -6.30M-$ -6.73M
Investing Cash Flow$ -120.92M$ -115.24M---
Financing Cash Flow$ 152.75M$ 938.00K$ 39.40M--
Currency in USD

Soleno Therapeutics Earnings and Revenue History

Soleno Therapeutics Debt to Assets

Soleno Therapeutics Cash Flow

Soleno Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis